Firebrick Pharma

Firebrick Pharma

Firebrick Pharma is an Australian pharmaceutical company founded in 2012 by Dr Peter Molloy and Dr Stephen Goodall with the mission to develop a nasal spray that kills all the germs (viruses or bacteria) responsible for respiratory infections, such as the common cold.

Latest